
|Articles|October 15, 2003
Allergan, Syntex involved in patent monopoly case
San Francisco-A federal judge will decide this fall whether a generic formulation of ketorolac tromethamine violates a patent held by Syntex Pharmaceuticals and licensed to Allergan Inc. to make Acular.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement


















